GEODE CAPITAL MANAGEMENT, LLC - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 35 filers reported holding ACER THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$113,096
+27.1%
136,955
+42.2%
0.00%
Q2 2023$88,951
+21.7%
96,3300.0%0.00%
Q1 2023$73,066
+30217.8%
96,3300.0%0.00%
Q4 2022$241
-99.8%
96,330
+6.1%
0.00%
Q3 2022$126,000
+10.5%
90,8150.0%0.00%
Q2 2022$114,000
-53.3%
90,815
+7.9%
0.00%
Q1 2022$244,000
+25.8%
84,171
-0.7%
0.00%
Q4 2021$194,000
+19.0%
84,761
+32.4%
0.00%
Q3 2021$163,000
-0.6%
64,024
+11.1%
0.00%
Q2 2021$164,000
+27.1%
57,609
+38.8%
0.00%
Q1 2021$129,000
+18.3%
41,498
-0.6%
0.00%
Q4 2020$109,000
-9.2%
41,7290.0%0.00%
Q3 2020$120,000
-16.1%
41,7290.0%0.00%
Q2 2020$143,000
+17.2%
41,729
-32.4%
0.00%
Q1 2020$122,000
-79.9%
61,764
-59.2%
0.00%
Q4 2019$606,000
+155.7%
151,506
+103.4%
0.00%
Q3 2019$237,000
-6.7%
74,485
+14.2%
0.00%
Q2 2019$254,000
-70.7%
65,246
+82.6%
0.00%
Q1 2019$868,000
-39.6%
35,736
-50.0%
0.00%
Q4 2018$1,438,000
+48.4%
71,472
+127.3%
0.00%
Q3 2018$969,00031,4390.00%
Other shareholders
ACER THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Nantahala Capital Management 1,136,416$1,049,3670.10%
Anson Funds Management LP 129,795$119,8530.02%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 60,000$550.01%
Hudson Bay Capital Management LP 274,300$253,2890.00%
UBS Group AG 33$300.00%
RHUMBLINE ADVISERS 347$3200.00%
OSAIC HOLDINGS, INC. 200$1840.00%
WELLS FARGO & COMPANY/MN 132$1220.00%
NORTHERN TRUST CORP 22,231$20,5280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ACER THERAPEUTICS INC shareholders